Genpact Limited (G) — Fair Value Analysis

Base-case fair value (P50): $38.28 · Current price: $35.79 · Verdict: Fairly Valued

The Verdict on G

Based on our Monte Carlo simulations, GENPACT LTD (G) is currently assessed as Fairly Valued. While the stock trades at $35.79, our median fair value (P50) stands at $38.28. This indicates an +7.0% potential against the current market price, suggesting the market largely recognizes G's intrinsic value as determined by our forward-looking model. This valuation reflects a comprehensive analysis of thousands of simulated future financial scenarios, anchoring our assessment of G's current standing.

How G stacks up against peers

GENPACT LTD's operational and financial health is categorized as average within its (n/a) sector. This "average" quality tier is a key input into our Monte Carlo framework, influencing the range and probability distribution of G's future cash flows. Despite this average standing, our simulations consistently place the stock's fair value around $38.28, confirming that its current trading price of $35.79 is largely aligned with its fundamental drivers. The +7.0% gap reinforces the view that G is not significantly overvalued or undervalued in the context of its industry peers and historical performance.

What this means for investors

For investors tracking GENPACT LTD, the "Fairly Valued" verdict signifies that the current market price of $35.79 offers approximately +7.0% to our calculated median fair value of $38.28. This narrow gap suggests that opportunities for substantial outperformance from a pure valuation arbitrage perspective may be limited at present. While there's a slight indicated upside, the stock's average quality tier, factored into our robust Monte Carlo simulations, supports this fair valuation. To explore the full probabilistic distribution of G's future scenarios, including specific bear-case and bull-case targets, sign up for FairCurve to see the full distribution and track G's fair value as new fundamentals are released.